United States· US:84989-009_448b7147-f045-c50a-e063-6294a90a2f75
XIMONTH GLP-1 Patches
A medicinal product containing acetyl hexapeptide-8 amide; rose oil, registered in United States by Shantou Ximonth Biotechnology Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ACETYL HEXAPEPTIDE-8 AMIDE; ROSE OIL
- Manufacturer
- Shantou Ximonth Biotechnology Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184989-009-01
- ndc11849890090130 mg in 1 PATCH (84989-009-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52be33cc-5349-426d-b411-08bf7eff9258 GET /v1/drugs/52be33cc-5349-426d-b411-08bf7eff9258?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".006; .006",
"substance": "ACETYL HEXAPEPTIDE-8 AMIDE; ROSE OIL",
"productndc": "84989-009",
"dosage_form": "PATCH",
"dea_schedule": null,
"strength_unit": "mg/30mg; mg/30mg",
"application_number": "M016",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about acetyl hexapeptide-8 amide; rose oil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.